Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

Published Date: 13 May 2024

DFS after three years was 87% after six years as opposed to 55% after three, but the toxicity was higher.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

As pesticides and wildfires rise, kids with cancer need resources

2.

Taking vitamin D daily decreased cancer mortality, according to a study.

3.

Recurrent UTIs impact eGFR in children with vesicoureteral reflux

4.

In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.

5.

Underprescribed for Alcohol Use Disorder is pharmacotherapy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot